Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Genosense Diagnostics is a biotechnology company based in Vienna, Austria, specializing in personalized medicine and pharmacogenetics. The company develops and provides genetic diagnostic tests designed to optimize drug therapy and improve patient outcomes by analyzing individual genetic profiles. Their services include nutrigenetics and lifestyle genetic testing, helping consumers and healthcare providers tailor treatments and diets to specific genetic predispositions. Genosense operates as a subsidiary of the Novogenia Group, leveraging advanced molecular biology techniques to deliver actionable health insights. The company's portfolio focuses on identifying genetic variations that affect drug metabolism and nutritional needs to support preventive healthcare.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on GENOSENSE Diagnostics.